• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Dow Soars on Signs of Progress in U.S.-China Trade Discussions
JIM CRAMER

More Positives Than Negatives: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Oct 21, 2019 10:45 PM EDT
Merck Slips After Announcing Acquisition of France's Antelliq Group
JIM CRAMER

Merck, Cloudflare, Exelon: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Oct 21, 2019 10:37 PM EDT
Sell These 6 Biotech Stocks Now Before It's Too Late
MARKETS

Seattle Genetics Shares Rise On Positive Results From Breast Cancer Drug Trial

  • By Brenda Bouw
  • Oct 21, 2019 11:04 AM EDT
Sell These 6 Biotech Stocks Now Before It's Too Late
STOCKS

Seattle Genetics Climbs on Positive Trial Results for Bladder Cancer Treatment

  • By Tony Owusu
  • Sep 30, 2019 1:15 PM EDT
Immunomedics Stock Drops After Bladder-Cancer-Drug Results Disappoint
STOCKS

Immunomedics Stock Drops After Bladder-Cancer-Drug Results Disappoint

  • By Tony Owusu
  • Sep 30, 2019 12:33 PM EDT
Market Indicator Is Bullish, Says No Recession Is Imminent
JIM CRAMER

Big Victory for the Bulls: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Jul 22, 2019 8:46 PM EDT
Berkshire Hathaway, Seattle Genetics, Zynerba: 'Mad Money' Lightning Round
JIM CRAMER

Berkshire Hathaway, Seattle Genetics, Zynerba: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Jul 22, 2019 8:35 PM EDT
Biotech Firm Sarepta Surges 40% on Positive Test Results
MARKETS

Biotech Stocks Post Double-Digit Gains in Monday Surge

  • By Scott Van Voorhis
  • Jan 7, 2019 6:49 PM EST
Cisco Analysts Reduce Price Targets on Guidance Miss: What Wall Street's Saying
JIM CRAMER

Cisco Systems, Herbalife, Under Armour: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Jul 12, 2018 6:33 AM EDT
Tariffs Fueling Rotation: Cramer's 'Mad Money' Recap (Wednesday 7/11/18)
JIM CRAMER

Tariffs Fueling Rotation: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Jul 12, 2018 6:22 AM EDT
Deere & Co., Analog Devices, Mercadolibre: 'Mad Money' Lightning Round
JIM CRAMER

Deere & Co., Analog Devices, Mercadolibre: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Jan 9, 2018 6:34 AM EST
Good News Matters in This Market: Cramer's 'Mad Money' Recap (Monday 1/8/18)
JIM CRAMER

Good News Matters in This Market: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Jan 9, 2018 6:26 AM EST
Catch of the Day: Cramer's 'Mad Money' Recap (Wednesday 10/11/17)
JIM CRAMER

Catch of the Day: Cramer's 'Mad Money' Recap (Wednesday 10/11/17)

  • By Scott Rutt
  • Oct 12, 2017 6:15 AM EDT
Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely
JIM CRAMER

Walgreens Boots Alliance, Snap, Teva: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Oct 5, 2017 6:38 AM EDT
A Tech Selloff and Fed Hangover Pull Markets From Records
JIM CRAMER

The Case for the Bears: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Oct 5, 2017 6:21 AM EDT
Flexion's Latest FDA Approval Reignites Takeover Chatter
STOCKS

Rigel Jumps on Update on FDA Review of Bleeding Disorder Treatment

  • By Armie Margaret Lee
  • Oct 2, 2017 9:26 AM EDT
Biotech Leaders Join Corporate Chorus Angry Over Trump's DACA Move
REGULATION

Biotech Leaders Join Corporate Chorus Angry Over Trump's DACA Move

  • By Bill Meagher
  • Sep 6, 2017 3:20 PM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Seattle Genetics, Valeant, ImmunoGen

  • By Armie Margaret Lee
  • Jun 26, 2017 9:32 PM EDT
Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: Clovis, Seattle Genetics, Rigel

  • By Armie Margaret Lee
  • Jun 19, 2017 9:08 AM EDT
Apple iPhone Shipment Estimates Slashed by 11 Million, Bank Sees 3-4 Week Delay in New Smartphone
STOCKS

Apple Could Explode Higher to $200 a Share If This Chart Pattern Is Correct

  • By Roberto Pedone
  • Jun 9, 2017 1:19 PM EDT
Analysts' Actions -- Amazon, CVS, Raytheon, Western Digital and More
STOCKS

Analysts' Actions -- Costco, J.C. Penney, Cisco, TherapeuticsMD and More

  • By TheStreet Staff
  • May 9, 2017 9:37 AM EDT
Mesoblast Soars on Stem-Cell Treatment Data
MERGERS AND ACQUISITIONS

Immunomedics, Seattle Genetics Scrap License Deal

  • By Armie Margaret Lee
  • May 5, 2017 4:32 PM EDT
Mesoblast Soars on Stem-Cell Treatment Data
HEALTH

Biotech Movers: Immunomedics Shares Jump After License Pact With Seattle Genetics Is Terminated

  • By Armie Margaret Lee
  • May 5, 2017 10:42 AM EDT
12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap (Tuesday 3/14/17)
JIM CRAMER

12 Years and Still Finding the Bulls for You: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Mar 14, 2017 8:25 PM EDT
Cisco Systems, CyberArk, Check Point Software: 'Mad Money' Lightning Round
JIM CRAMER

Cisco Systems, CyberArk, Check Point Software: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Mar 14, 2017 8:14 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.